Michel G Bergeron

This inventor holds 18 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 8 EPO patents. Top assignees: Geneohm Sciences Canada, Inc., Infectio Recherche Inc., Infectio Diagnostic, Inc.. Active years: 1984-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel G Bergeron. Retrieved from https://idiyas.com/inventor/michel-g-bergeron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 6)

% Patents Active = 61.1

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 8

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 510(Granted Patents)

Location History:

Montreal, CA (1984)
Sillery, CA (1998 - 2011)
Québec, CA (2007 - 2013)
Quebec, CA (1991 - 2018)

Company Filing History:

6 out of 20

Geneohm Sciences Canada, Inc.

patents

3 out of 3

Infectio Recherche Inc.

patents

2 out of 2

Infectio Diagnostic, Inc.

Genohm Sciences Canada, Inc.

patent

6. 1 out of 22

Mission Pharmacal Company

patents

7. 1 out of 16,025

University of California

patents

8. 4 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1984-2018

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10047404 - [object Object] (2018-08-14),

2. 9446024 - Formulations for the treatment of vaginal disorders (2016-09-20),

3. 8534319 - Serial siphon valves for fluidic or microfluidic devices (2013-09-17),

4. 8426137 - Methods and probes for detecting a vancomycin resistance gene (2013-04-23),

5. 8182996 - [object Object] (2012-05-22),

6. 8114601 - Highly conserved genes and their use to generate probes and primers for detection of microorganisms (2012-02-14),

7. 8067207 - Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories (2011-11-29),

8. 8034588 - Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories (2011-10-11),

9. 7943346 - Probes and primers for detection of bacterial pathogens and antibiotic resistance genes (2011-05-17),

10. 7465295 - Applicator for the delivery of topical formulations into mucosal cavities (2008-12-16),

11. 7357930 - Methods and formulations for targeting infectious agents bearing host cell proteins (2008-04-15),

12. 7192607 - Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities (2007-03-20),

13. 6068851 - Formulation for use in the prevention of pathogen induced diseases (2000-05-30),

14. 6001564 - Species specific and universal DNA probes and amplification primers to (1999-12-14),

15. 5994066 - Species-specific and universal DNA probes and amplification primers to (1999-11-30),

Title: Inventor Spotlight: Michel G. Bergeron

Introduction

Michel G. Bergeron, a prominent inventor based in Quebec, Canada, holds an impressive portfolio of 18 patents. His innovative contributions, particularly in the field of medical formulations, reflect his dedication to improving healthcare and addressing various medical conditions.

Latest Patents

Among his latest patents, Bergeron has developed compositions and methods for the detection of formulations for the treatment of vaginal disorders. This recent work provides novel formulations suitable for the intravaginal delivery of tinidazole, along with methods for their application. Such advancements have significant implications for women's health, offering new avenues for treatment.

Career Highlights

Throughout his career, Bergeron has made impactful strides in the biotechnological and pharmaceutical fields. He has worked with Geneohm Sciences Canada, Inc., where he harnessed his expertise to drive innovations in health-related technologies. His commitment to research and development has played a vital role in his successful patenting of groundbreaking medical solutions.

Collaborations

In his professional journey, Michel G. Bergeron has collaborated with several talented individuals, including Paul H. Roy and Marc Ouellette. These partnerships have facilitated the exchange of ideas and expertise, contributing to the advancement of their respective projects and reinforcing the importance of teamwork in innovation.

Conclusion

Michel G. Bergeron stands as a notable figure in the world of invention, with a strong focus on medical advancements. His contributions, underscored by a wealth of patents and collaborations, ensure his legacy in improving health outcomes through innovative solutions. As the landscape of healthcare continues to evolve, inventors like Bergeron are essential in paving the way for future breakthroughs.

Profile summary based on public USPTO records.